T-Cypher Bio
Jana Rundle has a diverse work experience in the field of scientific research. Jana currently holds the position of Principal Scientist at T-Cypher Bio starting from March 2023. Prior to this, they worked at Adaptimmune, where they held various roles. Jana served as a Principal Scientist in Display Technologies from January 2022 to March 2023. Before that, they held the position of Senior Scientist I Phage Display from January 2018 to January 2022, and Senior Scientist II Phage Display from August 2015 to January 2018. Jana also worked at the University of Oxford as a Postdoctoral Scientist from 2011 to August 2015. Their earliest work experience was as a Research Assistant at The University of Dundee from 2002 to 2006.
Jana Rundle earned their Bachelor's Degree in Molecular Genetics from King's College London between the years of 1999 and 2002. Subsequently, they pursued their Doctor of Philosophy (Ph.D.) in Medicine at the University of Dundee from 2006 to 2011.
T-Cypher Bio
T-Cypher Bio is an early-stage biotechnology company. T-Cypher Bio we believe that TCR-based therapeutics have the potential to transform the treatment of solid tumors, as well as autoimmune, inflammatory, and infectious diseases. Yet challenges in the identification of therapeutically relevant targets and TCRs have limited the application of suchtherapies.T-Cypher’s integrated platform, D-Cypher, overcomes these challenges.